Literature DB >> 1857224

Generation of antibodies and assays for transforming growth factor beta.

C Lucas, B M Fendly, V R Mukku, W L Wong, M A Palladino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1857224     DOI： 10.1016/0076-6879(91)98031-z

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats.

Authors:  T F Zioncheck; S A Chen; L Richardson; M Mora-Worms; C Lucas; D Lewis; J D Green; J Mordenti
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

2.  Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycin.

Authors:  L Yuan; Y Kuramitsu; Y Li; M Kobayashi; M Hosokawa
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

3.  Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractant.

Authors:  Y Kuramitsu; M Nishibe; M Kobayashi; Y Togashi; L Yuan; M Takizawa; F Okada; M Hosokawa
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

4.  Transforming growth factor beta production is inversely correlated with severity of murine malaria infection.

Authors:  F M Omer; E M Riley
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.